Cardiol Therapeutics Inc.
CRDL · Healthcare · $195M
$1.69+0.30%
Price
$1.05
$2.00
Jul 1, 26Sep 30, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$0M
6/'26 vs prev quarter
Company Health
Market Cap$195M
Short Float 3.0% · biweekly · settled 26.08.31
Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy7d ago
Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in ProceedsSep 16
5 Small Drug Stocks Poised to Benefit From a Biotech RecoverySep 14
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities CommissionSep 10
Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment ConferenceSep 9
Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis TrialAug 12
